• Furosemide injection, Fresenius Kabi
  10 mg/mL, 2 mL vial, 25 count (NDC 63323-0280-02)
  10 mg/mL, 10 mL vial, 25 count (NDC 63323-0280-10)

   

• • American Regent is not actively marketing furosemide injection.
  • Pfizer has furosemide injection on shortage due to manufacturing delays and increased demand.
  • Claris has furosemide injection available.
  • Fresenius Kabi has furosemide injection available.

• Furosemide injection, Claris
  10 mg/mL, 2 mL vial, 5 count (NDC 36000-0063-05)
  10 mg/mL, 2 mL vial, 25 count (NDC 36000-0282-25)
  10 mg/mL, 4 mL vial, 5 count (NDC 36000-0064-05)
  10 mg/mL, 4 mL vial, 25 count (NDC 36000-0283-25)
  10 mg/mL, 10 mL vial, 5 count (NDC 36000-0065-05)
  10 mg/mL, 10 mL vial, 25 count (NDC 36000-0284-25)
  
  Furosemide injection, Fresenius Kabi
  10 mg/mL, 4 mL vial, 25 count (NDC 63323-0280-04)
  
  Furosemide injection, Pfizer
  10 mg/mL, 2 mL vial, 25 count (NDC 00409-6102-02)
  10 mg/mL, 4 mL syringe, 10 count (NDC 00409-9631-04)

Estimated Resupply Dates

• • Fresenius Kabi has furosemide 10 mg/mL 2 mL and 10 mL vials on back order with an estimated release date of mid-August 2017 for the 2 mL vials and early-August 2017 for the 10 mL vials.
  • Pfizer has furosemide 10 mg/mL 10 mL syringes on back order and the company estimates a release date of late-July 2017. The 10 mg/mL 4 mL and 10 mL vials are on back order and the company estimates a release date of late-July 2017 for the 4 mL vials and September 2017 for the 10 mL vials.